Reply to Ward and Colleagues’ Comment on “Using Human Experiments of Nature to Predict Drug Safety Issues: An Example With PCSK9 Inhibitors”

Drug Safety - United Kingdom
doi 10.1007/s40264-018-0701-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example With PCSK9 Inhibitors”

Drug Safety
ToxicologyPharmacology
2018English

Reply to Groome and Colleagues

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
2020English

Authors’ Reply to Lee and Colleagues

British Medical Journal
Medicine
2015English

Authors' Reply to Rappuoli and Colleagues, Black, and Glennie and Colleagues

British Medical Journal
Medicine
2014English

Comment to the Reply On:

Journal of the American Society for Mass Spectrometry
Structural BiologySpectroscopy
2014English

Mice With Human Ectopic Artificial Livers (HEALs) to Predict Human Drug Metabolism and Drug-Drug Interactions

Science-Business eXchange
2011English

Response to Comment by P. Vassilakopoulos and Colleagues

Haematologica
Hematology
2015English

Dr. Addington and Colleagues Reply to Methodological Issues in a Comparative Study of Ziprasidone and Risperidone

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2006English

Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice

Postgraduate Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy